Sign in Subscribe
Genetic research

Researchers Reveal Key Role of OCT4 in DNA Damage Response in Gastric Cancer

Strategic Insights

— 1 min read

New research has shed light on the crucial role of the transcription factor OCT4 in the DNA damage response mechanism, particularly in the treatment of gastric cancer. The study, conducted by researchers at Shanxi Medical University, found that OCT4 plays a significant role in regulating DNA methyltransferase 1 (DNMT1) in cisplatin-treated gastric cancer cells. The findings suggest that targeting OCT4 could enhance the effectiveness of cisplatin treatment by promoting cell apoptosis and proliferation inhibition.

Key Takeaways:

  • The study reveals that OCT4 plays a crucial role in the DNA damage response mechanism, particularly in the treatment of gastric cancer.
  • OCT4 regulates DNA methyltransferase 1 (DNMT1) in cisplatin-treated gastric cancer cells.
  • Targeting OCT4 may enhance the effectiveness of cisplatin treatment by promoting cell apoptosis and proliferation inhibition.
  • The researchers used a dual-luciferase reporter assay to detect the relationship between DNMT1 and OCT4.
  • Human gastric cancer cell lines HGC-27 and MGC-803 were transfected with siRNA-OCT4 or ov-DNMT1 to construct interfering cell lines.
  • The study found that overexpression of DNMT1 reversed the siRNA-OCT4-induced cell apoptosis, gamma-H2AX upregulation, and proliferation decrease.
  • The research suggests that OCT4 silence may target DNMT1 to induce DDR in GC cells to strengthen the CDDP-induced cell apoptosis and proliferation inhibition.

Statistics:

  • The study used a variety of methods, including Western blot, cell cloning, and flow cytometry, to assess the effects of CDDP treatment on cell apoptosis and proliferation.
  • The IC50 of CDDP-treated GC cells was reduced by OCT4 silence but enhanced by DNMT1 overexpression.
  • The expression of OCT4 and DNMT1 was increased in CDDP-treated cells, while DNMT1 was decreased in the siRNA-OCT4 group.
  • The study found that the targeted regulatory relationship between OCT4 and DNMT1 was crucial for the induction of DDR in GC cells.

Sources:

  • The Stem Cell Transcription Factor Oct4 Silences Target Dna Methyltransferase 1 To Strengthen Dna Damage Response In Cisplatin-treated Gastric Cancer Cells. Biotechnology and Applied Biochemistry, 2025.
  • Wang Z, et al. (2025). Researchers from Shanxi Medical University Detail New Studies and Findings in the Area of Gastric Cancer (The Stem Cell Transcription Factor Oct4 Silences Target Dna Methyltransferase 1 To Strengthen Dna Damage Response In Cisplatin-treated ...). Cancer Weekly. June 24, 2025; p 358.

Read more